Identification of a clinical isolate of HIV-1 with an isoleucine at position 82 of the protease which retains susceptibility to protease inhibitors
- 30 September 1995
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 28 (1) , 13-24
- https://doi.org/10.1016/0166-3542(95)00033-i
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Multiple Mutations in the Human Immunodeficiency Virus Protease Gene Are Responsible for Decreased Susceptibility to Protease InhibitorsAntiviral Chemistry and Chemotherapy, 1995
- Biological, Serological, and Genetic Characterization of HIV-1 Subtype E Isolates from Northern ThailandAIDS Research and Human Retroviruses, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- In vitro Resistance to an Inhibitor of HIV Proteinase (Ro 31-8959) Relative to Inhibitors of Reverse Transcriptase (AZT and TIBO)Antiviral Chemistry and Chemotherapy, 1993
- In vitro Selection of Human Immunodeficiency Virus Type 1 Resistant to Ro 31-8959 Proteinase InhibitorAntiviral Chemistry and Chemotherapy, 1993
- Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working GroupAntimicrobial Agents and Chemotherapy, 1993
- PCR amplification of HIV-1 proteinase sequences directly from Lab isolates allows determination of five conserved domainsVirology, 1992
- X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymesNature, 1989
- Complete mutagenesis of the HIV-1 proteaseNature, 1989
- Human immunodeficiency virus proteasePublished by Elsevier ,1989